How to Get Alprostadil (Caverject/MUSE) in Ohio

What Alprostadil Is and Why It Requires a Prescription

Alprostadil is synthetic prostaglandin E1. It relaxes smooth muscle in the corpus cavernosum and dilates penile arteries, producing an erection independent of sexual arousal or nitric-oxide pathways. Because it bypasses the PDE5 mechanism, it works in men who fail sildenafil or tadalafil entirely.

The FDA approved the intracavernosal formulation (Caverject) in July 1995 and the intraurethral pellet (MUSE) in 1996. Both formulations require a prescription because dose titration must be supervised: an incorrectly self-administered starting dose can cause priapism, a urological emergency. The FDA labeling for Caverject specifies that the first injection must occur in a clinical setting with a 30-minute observation window. Caverject FDA label

The landmark Linet et al. trial published in the New England Journal of Medicine (N=296 men with erectile dysfunction of organic origin) demonstrated that intracavernosal alprostadil produced erections sufficient for intercourse in 94% of in-office titration attempts versus 8% with placebo injections. [1] That efficacy gap is why this drug has remained a first-line parenteral option for over 28 years despite the widespread adoption of oral PDE5 inhibitors.

Alprostadil is also used off-label as a component in trimix (alprostadil plus papaverine plus phentolamine) compounded by 503A pharmacies. Trimix typically allows lower individual alprostadil doses, which can reduce injection-site pain. [2]

Ohio Telehealth Rules That Apply to Alprostadil Prescribing

Ohio explicitly permits telehealth prescribing of non-controlled medications following a synchronous audio-video evaluation. Ohio Revised Code Section 4731.296 (effective 2023) requires the prescriber to establish a valid patient-provider relationship, review relevant medical history, and document clinical findings before issuing any prescription electronically. [3]

Alprostadil is not a controlled substance under Ohio law or federal DEA scheduling, so telehealth providers face no Schedule II/III barrier that complicates prescribing of, say, testosterone or buprenorphine. A licensed MD, DO, PA, or CNP practicing in Ohio may prescribe alprostadil via telehealth. The prescriber must hold an Ohio license or a valid multi-state compact license recognized by Ohio.

The practical workflow runs as follows. A patient completes an intake form covering cardiovascular history, current medications, prior ED treatments, and any contraindications such as anatomical deformity or anticoagulant use. The provider conducts a video visit, typically 15 to 30 minutes. If appropriate, the provider issues a prescription electronically to a pharmacy of the patient's choice or arranges shipment from a compounding pharmacy. A follow-up call at 2 to 4 weeks confirms tolerability and allows dose adjustment. [4]

Ohio telehealth prescribers are permitted to order laboratory work before or after the initial visit. Most providers require a basic metabolic panel, testosterone level, and fasting lipid panel to rule out endocrine causes of ED and assess cardiovascular baseline before initiating therapy. [5]

How to Get an Alprostadil Prescription Step by Step in Ohio

Getting alprostadil in Ohio is a three-step process: establish care, complete the in-office or telehealth titration protocol, and fill the prescription.

Step 1. Choose a provider. Options include a urologist at an academic center (Ohio State Wexner Medical Center, Cleveland Clinic, University Hospitals), a men's health telehealth platform licensed in Ohio, or a primary care physician comfortable with sexual medicine. Urology practices typically handle the first-injection titration in-office. Telehealth providers may coordinate the first titration with a local urology office or, for MUSE, handle titration telephonically because urethral suppositories carry lower priapism risk than injections. [6]

Step 2. Complete the required evaluation. Ohio's standard of care mirrors the American Urological Association (AUA) 2018 Erectile Dysfunction Guideline, which recommends a detailed sexual, medical, and psychosocial history; a focused physical exam; and baseline labs including total testosterone, HbA1c, and a fasting lipid panel. [7] Telehealth providers fulfill the physical-exam requirement through a structured patient self-report form or a hybrid model where the patient's primary care physician provides exam findings.

Step 3. Fill and train. After the prescription is issued, a retail pharmacist or compounding pharmacy ships the medication. Because the first intracavernosal injection must be supervised, patients either return to the prescribing office or complete injection training via video. The FDA label stipulates that self-injection training is mandatory before home use. [8] MUSE suppositories require less technical training and can be taught via instructional video with provider oversight.

Ohio Pharmacies That Carry Alprostadil

Brand-name Caverject Impulse (Pfizer) and generic alprostadil for injection are stocked at many large retail chains in Ohio, including CVS, Walgreens, and Kroger Pharmacy, though availability varies by location. Call ahead before sending a prescription to confirm stock, because the branded product has experienced periodic supply disruptions since 2020. [9]

MUSE urethral suppositories (Meda Pharmaceuticals) are less consistently stocked at retail locations and are frequently special-ordered, adding 2 to 5 business days. Ask the pharmacist to verify the MUSE lot is within date before dispensing, as short shelf life occasionally causes problems.

503A compounding pharmacies in Ohio can prepare alprostadil for intracavernosal injection at custom concentrations and in multi-dose vials, which significantly reduces per-dose cost versus the branded product. The Ohio State Board of Pharmacy licenses 503A compounders; patients can verify a pharmacy's license at the board's public database at pharmacy.ohio.gov. A 503A pharmacy may dispense pursuant to an individual patient prescription only, not in bulk. [10] Compounded trimix containing alprostadil, papaverine, and phentolamine is the most frequently requested formulation at Ohio 503A pharmacies because the multi-drug combination allows the alprostadil component to stay below the 10 to 20 mcg range where pain is most common with alprostadil alone. [11]

Ohio 503A Alprostadil Sourcing Decision Framework

Use branded Caverject or generic alprostadil from a retail chain when: the patient has commercial insurance with a usable pharmacy benefit, the dose is within the standard range of 5 to 40 mcg, and no trimix is needed. Use a licensed Ohio 503A compounder when: the patient is self-pay, the provider prescribes trimix, or dose customization beyond commercial vial sizes is required. Confirm the 503A pharmacy ships within Ohio (all licensed 503A compounders may ship intrastate; interstate shipment adds federal CSOS requirements for certain formulations). [12]

Dosing and Administration Basics

Starting doses and titration schedules differ between formulations. Both are on-demand drugs; neither is taken daily.

Caverject / generic alprostadil injection. The FDA-approved starting dose for vasculogenic or psychogenic ED is 1.25 mcg, titrated upward by 1.25 mcg to 2.5 mcg increments at each supervised visit until an erection sufficient for intercourse but lasting no longer than 60 minutes is achieved. The maximum labeled dose is 60 mcg per injection. [8] Most patients respond between 5 mcg and 20 mcg. Injections should not exceed one per 24 hours and no more than three per week.

MUSE urethral suppository. Initial doses are 125 mcg or 250 mcg placed intraurethrally with the supplied ACTIS delivery system. The dose may be increased to 500 mcg or 1 to 000 mcg based on response. In the key MUSE trial (N=1,511), 64.9% of men who achieved erections in the clinic also had erections sufficient for intercourse at home with the 500 mcg to 1 to 000 mcg doses, compared with 18.6% on placebo. [13]

Injection-site pain affects approximately 37% of patients in long-term alprostadil monotherapy use; switching to trimix or adjusting concentration may reduce that figure substantially. A 2003 study in the Journal of Urology (N=102) found that compounded trimix reduced pain scores by approximately 50% compared with alprostadil alone at equivalent erectile quality. [2]

Priapism, defined as erection persisting beyond 4 hours, occurs in roughly 1% of patients during home use. Patients must receive written and verbal instructions to seek emergency care immediately for any erection lasting more than 4 hours. [14]

Prior Authorization in Ohio: What Documentation You Need

Ohio commercial insurers and some employer-sponsored plans cover alprostadil for refractory ED, but prior authorization is nearly universal. Ohio Medicaid (ODM) does not cover alprostadil for erectile dysfunction except in the setting of Type 2 diabetes as a recognized comorbidity, and even then coverage is plan-specific. [15]

For a PA submission, the prescribing provider typically must document: a diagnosis of erectile dysfunction with ICD-10 code N52.x; failure of at least one oral PDE5 inhibitor (sildenafil, tadalafil, or vardenafil) at an adequate dose and duration (typically 4 to 8 weeks); a clinical rationale for why the oral agent failed or is contraindicated (for example, concurrent nitrate use); baseline cardiovascular risk assessment; and the intended alprostadil formulation and dose. [16]

Some Ohio Blue Cross Blue Shield and Anthem plans additionally require documentation of testosterone level and, when testosterone is low, a note that testosterone replacement has been considered or initiated. Medical records from the treating provider plus the most recent lab results should be submitted together. Turnaround for PA decisions in Ohio runs 3 to 5 business days for standard reviews and 24 hours for expedited urgent cases under Ohio's managed care rules. [17]

If the PA is denied, Ohio patients have the right to request an internal appeal within 60 days of the denial notice. A peer-to-peer call between the prescribing physician and the insurer's medical director resolves many first-level denials, particularly when the clinical chart clearly shows PDE5 inhibitor failure. [17]

Transferring an Existing Alprostadil Prescription to Ohio

Patients relocating to Ohio with an existing alprostadil prescription from another state can transfer it to an Ohio retail pharmacy if the prescription was issued by a provider with prescribing authority recognized in Ohio and the prescription has remaining refills. Ohio allows transfer of non-controlled drug prescriptions between licensed pharmacies in different states, provided the original pharmacy releases the remaining refills electronically or by fax. [18]

If the prescription was issued by a telehealth provider in another state whose license is not valid in Ohio, a new evaluation by an Ohio-licensed provider is required. Most telehealth platforms operating in Ohio can schedule a new-patient visit within 48 to 72 hours and issue a fresh prescription if clinically appropriate.

Compounded alprostadil or trimix from a 503A pharmacy in another state raises an additional consideration. The compounding pharmacy must hold an Ohio 503A license or a non-resident pharmacy permit issued by the Ohio Board of Pharmacy to ship into Ohio legally. Verify permit status before requesting a transfer of a compounded formulation. [10]

What to Expect After Starting Alprostadil in Ohio

The majority of patients with vasculogenic, diabetic, or post-prostatectomy ED achieve a clinically useful erection with alprostadil when titrated correctly. The Linet et al. NEJM trial found that 87% of at-home injection attempts produced erections rated as satisfactory by patients, compared with 24% in the placebo group (P<0.001). [1]

Realistic expectations include: a 5- to 20-minute onset after injection, a 30- to 60-minute erection duration at a properly titrated dose, mild penile aching in roughly one-third of users, and a slow reduction in efficacy over years if underlying vascular disease progresses. [14]

Patients who use alprostadil alongside a vacuum erection device (VED) may achieve better rigidity at lower doses, according to a randomized crossover study in Urology (N=54), which reported a 28% reduction in required alprostadil dose when combined with a VED compared with injection alone. [19]

Follow-up visits at 1 month, 3 months, and then annually are standard at most Ohio urology practices. At each visit, the provider reassesses dose adequacy, injection technique, and any signs of penile fibrosis (Peyronie-like plaques), which develop in approximately 3% of long-term alprostadil injection users. [14] Early detection allows adjustment of injection site rotation and, if needed, evaluation for collagenase clostridium histolyticum (Xiaflex) treatment. [20]

Insurance, Cost, and Self-Pay Options in Ohio

Brand-name Caverject Impulse (Pfizer, 10 mcg/vial) retails at approximately $65 to $90 per single-use vial in Ohio without insurance. A 20 mcg vial runs $90 to $130. The MUSE suppository at 1 to 000 mcg lists near $90 per unit. At two to three uses per week, monthly costs for brand-name product reach $520 to $1,170, making insurance or compounding critical for long-term adherence. [9]

Generic alprostadil for injection is available from several manufacturers at significantly lower cost, typically $20 to $45 per vial at Ohio retail pharmacies. GoodRx and similar discount programs apply.

Compounded alprostadil from an Ohio 503A pharmacy typically costs $40 to $80 for a 5 mL multi-dose vial (at 20 mcg/mL, that is approximately 50 doses), dropping per-dose cost to under $2. Trimix multi-dose vials run $60 to $120 for a comparable supply. These prices exclude the pharmacy's dispensing and compounding fee, which averages $15 to $30 per order at Ohio compounders. [11]

The AUA's 2018 guideline on erectile dysfunction states: "Vacuum erection devices and intracavernosal injection therapy should be offered to patients who do not desire surgery and who have failed or are unable to use PDE5 inhibitors." [7] That language supports insurance medical necessity arguments for alprostadil in PA submissions when oral therapy has failed.

Contraindications and Safety Flags Ohio Providers Screen For

Not every man with ED is a candidate for alprostadil. Providers in Ohio, whether in-office or via telehealth, screen for absolute and relative contraindications before prescribing. [8]

Absolute contraindications include: known hypersensitivity to alprostadil; predisposition to priapism (sickle cell disease, sickle cell trait, multiple myeloma, leukemia); penile implant in situ; and anatomical deformity that would preclude safe injection (severe Peyronie's disease with plaque overlying the injection site). [14]

Relative contraindications include: anticoagulant therapy (warfarin, apixaban, rivaroxaban) where hematoma risk at the injection site is elevated; bleeding disorders; and urethral stricture or active urinary tract infection for MUSE. Men on anticoagulants may still use alprostadil if the prescriber documents a favorable risk-benefit analysis and teaches meticulous post-injection compression technique. [6]

Cardiovascular clearance follows the Princeton III Consensus guidelines, which stratify men with ED into low, intermediate, and high cardiovascular risk categories. Men with low-risk profiles (asymptomatic, fewer than three major CAD risk factors, controlled hypertension) may begin alprostadil without further cardiac workup. [21] Men in the intermediate or high-risk categories require cardiology evaluation before initiating any ED therapy. Ohio telehealth providers apply the same stratification during intake, requesting a cardiology clearance note when indicated.